Cryopreserved hematopoietic stem/progenitor cells stability program‐development, current status and recommendations: A brief report from the AABB‐ISCT joint working group cellular therapy product stability project team-Reference-Cited by-同舟云学术

Cryopreserved hematopoietic stem/progenitor cells stability program‐development, current status and recommendations: A brief report from the AABB‐ISCT joint working group cellular therapy product stability project team

Published:2022-03 Issue:3 Volume:62 Page:651-662
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Reich‐Slotky Ronit¹^ORCID,Vasovic Ljiljana V.²^ORCID,Land Kevin J.³⁴^ORCID,Halpenny Mike⁵,Woeltz Joan⁶,Mathew Aby J.⁷,Fournier Diane⁸,Alder Brenda⁹,Stasko Karl¹⁰,Mahmud Nadim¹¹^ORCID

Affiliation:

1. John Theurer Cancer Center Hackensack University Medical Center Hackensack New Jersey USA

2. Weill Cornell Medicine New York‐Presbyterian Hospital New York New York USA

3. Vitalant Biotherapies Phoenix Arizona USA

4. University of Texas Health Science Center San Antonio, Department of Pathology Transfusion Medicine San Antonio Texas USA

5. Canadian Blood Services Ottawa Ontario Canada

6. Blood & Marrow Transplantation and Cellular Therapy Stanford Health Care Stanford California USA

7. BioLife Solutions, Inc. Bothell Washington USA

8. Héma‐Québec Montreal Quebec Canada

9. Northside Hospital, Blood and Marrow Transplant Program, Cell Therapy Lab Atlanta Georgia USA

10. Dana‐Farber Cancer Institute Cell Manipulation Core Facility Boston Massachusetts USA

11. Division of Hematology/Oncology, Department of Medicine University of Illinois College of Medicine Chicago Illinois USA

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16820

Reference43 articles.

1. Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates

2. Avoiding room temperature storage and delayed cryopreservation provide better postthaw potency in hematopoietic progenitor cell grafts

3. Long-term effects of cryopreservation on clinically prepared hematopoietic progenitor cell products

4. Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience

5. Code of federal regulation Human cells tissues and cellular and tissue‐based products. Title 21 CFR Part 1271. In. Washington DC: US Government Printing Office; 2020 (revised annualy).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A machine-learning model that incorporates CD45 surface expression predicts hematopoietic progenitor cell recovery after freeze–thaw;Cytotherapy;2023-10

2. Serious Stem Cell Donation Events and Recipient Adverse Reactions Related to Severe Acute Respiratory Syndrome Coronavirus 2: Review of Reports to the World Marrow Donor Association;Transplantation and Cellular Therapy;2023-08

3. Effects of extended transport on cryopreserved allogeneic hematopoietic progenitor cell (HPC) product quality and optimal methods to assess HPC stability;Transfusion;2023-03-28